Skip to content
Nautilus Biotechnology, Inc. logo

Nautilus Biotechnology, Inc. (NAUT) Q1 2024 Earnings

NAUT·Reported April 30, 2024·Before market open

Diluted EPS came in at $-0.15, beat the $-0.16 consensus by $0.01.

Diluted EPS
$-0.15beat by $0.01
Consensus: $-0.16
SEC

SEC Filings

Financial Snapshot

Trailing eight quarters through Q1 2024

Q1 2024 Earnings FAQ

Common questions about Nautilus Biotechnology, Inc.'s Q1 2024 earnings report.

Nautilus Biotechnology, Inc. (NAUT) reported Q1 2024 earnings on April 30, 2024 before market open.

Nautilus Biotechnology, Inc. reported diluted EPS of $-0.15 for Q1 2024.

EPS beat the consensus estimate of $-0.16 by $0.01.

You can read the 8-K earnings release (0001808805-24-000038) and the 10-Q periodic report (0001808805-24-000041) directly on SEC EDGAR. The filing index links above go to sec.gov.